<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30744292</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0253-9624</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]</Title><ISOAbbreviation>Zhonghua Yu Fang Yi Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Etiologic surveillance and analysis of acute meningitis and encephalitis syndrome in Jinan city in 2013-2016].</ArticleTitle><Pagination><StartPage>174</StartPage><EndPage>178</EndPage><MedlinePgn>174-178</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0253-9624.2019.02.010</ELocationID><Abstract><AbstractText><b>Objective:</b> To characterize the etiology and epidemiological characteristics of the acute meningitis and encephalitis syndrome (AMES) in Jinan city in 2013-2016. <b>Methods:</b> The epidemiological data, clinical diagnosis, serum and cerebrospinal fluid (CSF) specimens were collected from 3 577 AMES cases in 6 sentinel hospitals in Jinan city in 2013-2016. Samples of all cases were made sero-diagnosis for Immunoglobulin (Ig) M antibody to Japanese encephalitis virus (JEV) and negative cases of JEV for enterovirus (EV), mumps virus (MuV) and herpes simplex virus (HSV) by enzyme-linked immunosorbent assay (ELISA). Virus isolation and molecular identification were performed. Positive rates were analyzed by Chi-square test. <b>Results:</b> In 2013-2016, the positive rates of JEV, EV, MuV and HSV were 9.0% (322/3 577 cases), 22.1% (643/2 916 cases), 9.9% (289/2 916 cases), 26.9% (783/2 916), respectively. Of these, the positive rates of JEV were 32.9% (261/794), 1.2% (14/1 175), 1.0% (8/807) and 4.9% (39/801 cases); EV: 19.5% (91/466), 35.1% (342/974 cases), 15.5% (115/743) and 13.0% (95/733); MuV: 9.2% (43/466), 14.4% (140/974), 9.0% (67/743) and 5.3% (39/733). HSV: 35.4% (165/466), 38.5% (375/974), 25.7% (191/743) and 7.1% (52/733). There were significant differences in positive rates of 4 kinds of viruses in 2013-2016 (<i>P</i>&lt;0.001). A total of 81 EV strains belonging to 8 serotypes were isolated from 1 020 CSF specimens. The positive rates were 4.8% (6 cases), 13.1% (55 cases), 4.1% (7 cases) and 4.2% (13 cases) from 2013 to 2016. Coxsackievirus (CV) B5, echovirus (E) 6 and E30 accounted for 46% (37 isolates), 22% (18 isolates) and 21% (17 isolates) of all strains. <b>Conclusion:</b> The AMES cases in Jinan city in 2013-2016 were mainly caused by HSV, EV, MuV, JEV. CVB5, E6 and E30 were the dominant serotypes of EV associated with AMES cases in Jinan city.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>X J</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Division of Expanded Immunization Program, Shandong Center for Disease Control and Prevention; Academy of Preventive Medicine, Shandong University; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Jinan 250014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>G F</ForeName><Initials>GF</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Z X</ForeName><Initials>ZX</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>S T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>L Z</ForeName><Initials>LZ</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>A Q</ForeName><Initials>AQ</Initials></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>ts.201511105</GrantID><Agency>Taishan Scholar Program of Shandong Province</Agency><Country/></Grant><Grant><GrantID>2013ZXl0004-202</GrantID><Agency>National Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>LYH2017-05</GrantID><Agency>Zhi Fei Research Foundation Programme on Disease Control and Prevention Technology from Shandong preventive Medicine Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Yu Fang Yi Xue Za Zhi</MedlineTA><NlmUniqueID>7904962</NlmUniqueID><ISSNLinking>0253-9624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002947" MajorTopicYN="N" Type="Geographic">Cities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="N">Encephalitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008581" MajorTopicYN="N">Meningitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018571" MajorTopicYN="Y">Sentinel Surveillance</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x4e86;&#x89e3;2013&#x2014;2016&#x5e74;&#x6d4e;&#x5357;&#x5e02;&#x54e8;&#x70b9;&#x533b;&#x9662;&#x6025;&#x6027;&#x8111;&#x819c;&#x708e;&#x8111;&#x708e;&#x75c7;&#x5019;&#x7fa4;&#xff08;AMES&#xff09;&#x76d1;&#x6d4b;&#x75c5;&#x4f8b;&#x7684;&#x75c5;&#x6bd2;&#x6d41;&#x884c;&#x7279;&#x5f81;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x6536;&#x96c6;2013&#x2014;2016&#x5e74;&#x6d4e;&#x5357;&#x5e02;6&#x5bb6;AMES&#x54e8;&#x70b9;&#x76d1;&#x6d4b;&#x533b;&#x9662;&#x4e0a;&#x62a5;&#x7684;AMES&#x76d1;&#x6d4b;&#x75c5;&#x4f8b;&#x7684;&#x4e2a;&#x6848;&#x8c03;&#x67e5;&#x8d44;&#x6599;&#x3001;&#x4e34;&#x5e8a;&#x4fe1;&#x606f;&#x7b49;&#xff0c;&#x5e76;&#x9009;&#x53d6;&#x5176;&#x8840;&#x6e05;&#x548c;&#xff08;&#x6216;&#xff09;&#x8111;&#x810a;&#x6db2;&#x6807;&#x672c;&#x8fdb;&#x884c;&#x5b9e;&#x9a8c;&#x5ba4;&#x68c0;&#x6d4b;&#xff0c;&#x5171;3 577&#x4f8b;&#x3002;&#x91c7;&#x7528;ELISA&#x65b9;&#x6cd5;&#x68c0;&#x6d4b;&#x6d41;&#x884c;&#x6027;&#x4e59;&#x578b;&#x8111;&#x708e;&#x75c5;&#x6bd2;&#xff08;JEV&#xff09;IgM&#x6297;&#x4f53;&#xff1b;&#x5bf9;JEV IgM&#x6297;&#x4f53;&#x9634;&#x6027;&#x8005;&#x8fdb;&#x884c;&#x4eba;&#x7c7b;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#xff08;EV&#xff09;&#x3001;&#x6d41;&#x884c;&#x6027;&#x816e;&#x817a;&#x708e;&#x75c5;&#x6bd2;&#xff08;MuV&#xff09;&#x548c;&#x5355;&#x7eaf;&#x75b1;&#x75b9;&#x75c5;&#x6bd2;&#xff08;HSV&#xff09;&#x7684;IgM&#x6297;&#x4f53;&#x68c0;&#x6d4b;&#xff1b;&#x5e76;&#x8fdb;&#x884c;EV&#x5206;&#x79bb;&#x4e0e;&#x5206;&#x5b50;&#x5b9a;&#x578b;&#x3002;&#x6bd4;&#x8f83;4&#x79cd;&#x75c5;&#x6bd2;IgM&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x7684;&#x5dee;&#x5f02;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> 2013&#x2014;2016&#x5e74;JEV IgM&#x6297;&#x4f53;&#x68c0;&#x6d4b;&#x4f8b;&#x6570;&#x4e3a;3 577&#x4f8b;&#xff0c;&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x4e3a;9.0%&#xff08;322&#x4f8b;&#xff09;&#x3002;3 255&#x4f8b;JEV IgM&#x6297;&#x4f53;&#x9634;&#x6027;&#x8005;&#x4e2d;&#xff0c;EV&#x3001;MuV&#x548c;HSV IgM&#x6297;&#x4f53;&#x68c0;&#x6d4b;&#x4f8b;&#x6570;&#x4e3a;2 916&#x4f8b;&#xff0c;&#x9633;&#x6027;&#x7387;&#x5206;&#x522b;&#x4e3a;22.1%&#xff08;643&#x4f8b;&#xff09;&#x3001;9.9%&#xff08;289&#x4f8b;&#xff09;&#x548c;26.9%&#xff08;783&#x4f8b;&#xff09;&#x3002;&#x5404;&#x5e74;JEV IgM&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x5206;&#x522b;&#x4e3a;32.9%&#xff08;261/794&#xff09;&#x3001;1.2%&#xff08;14/1 175&#xff09;&#x3001;1.0%&#xff08;8/807&#xff09;&#x548c;4.9%&#xff08;39/801&#xff09;&#xff0c;EV IgM&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x5206;&#x522b;&#x4e3a;19.5%&#xff08;91/466&#xff09;&#x3001;35.1%&#xff08;342/974&#xff09;&#x3001;15.5%&#xff08;115/743&#xff09;&#x548c;13.0%&#xff08;95/733&#xff09;&#xff0c;MuV IgM&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x5206;&#x522b;&#x4e3a;9.2%&#xff08;43/466&#xff09;&#x3001;14.4%&#xff08;140/974&#xff09;&#x3001;9.0%&#xff08;67/743&#xff09;&#x548c;5.3%&#xff08;39/733&#xff09;&#xff0c;HSV IgM&#x6297;&#x4f53;&#x9633;&#x6027;&#x7387;&#x5206;&#x522b;35.4%&#xff08;165/466&#xff09;&#x3001;38.5%&#xff08;375/974&#xff09;&#x3001;25.7%&#xff08;191/743&#xff09;&#x548c;7.1%&#xff08;52/733&#xff09;&#xff1b;4&#x79cd;&#x75c5;&#x6bd2;&#x5404;&#x5e74;&#x4efd;&#x95f4;&#x9633;&#x6027;&#x7387;&#x5dee;&#x5f02;&#x5747;&#x6709;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i>&lt;0.001&#xff09;&#x3002;2013&#x2014;2016&#x5e74;&#x5171;&#x5bf9;1 020&#x4f8b;&#x75c5;&#x4f8b;&#x8111;&#x810a;&#x6db2;&#x6807;&#x672c;&#x8fdb;&#x884c;&#x4e86;EV&#x5206;&#x79bb;&#xff0c;&#x68c0;&#x51fa;&#x7387;&#x4e3a;7.9%&#xff08;81&#x4f8b;&#xff09;&#xff0c;&#x5404;&#x5e74;&#x5206;&#x522b;&#x4e3a;4.8%&#xff08;6&#x4f8b;&#xff09;&#x3001;13.1%&#xff08;55&#x4f8b;&#xff09;&#x3001;4.1%&#xff08;7&#x4f8b;&#xff09;&#x548c;4.2%&#xff08;13&#x4f8b;&#xff09;&#xff1b;81&#x682a;EV&#x5206;&#x4e3a;8&#x4e2a;&#x8840;&#x6e05;&#x578b;&#xff0c;&#x5176;&#x4e2d;&#x67ef;&#x8428;&#x5947;&#x75c5;&#x6bd2;&#xff08;CV&#xff09;B5&#x578b;&#x3001;&#x57c3;&#x53ef;&#x75c5;&#x6bd2;&#xff08;E&#xff09;6&#x548c;30&#x578b;&#x8f83;&#x591a;&#xff0c;&#x5206;&#x522b;&#x5360;46%&#xff08;37&#x682a;&#xff09;&#x3001;22%&#xff08;18&#x682a;&#xff09;&#x548c;21%&#xff08;17&#x682a;&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> 2013&#x2014;2016&#x5e74;&#x6d4e;&#x5357;&#x5e02;&#x54e8;&#x70b9;&#x533b;&#x9662;AMES&#x75c5;&#x4f8b;&#x7684;&#x75c5;&#x6bd2;&#x75c5;&#x539f;&#x4e3b;&#x8981;&#x4e3a;HSV&#x3001;EV&#x3001;MuV&#x3001;JEV&#xff1b;CV-B5&#x3001;E6&#x548c;E30&#x662f;&#x5f15;&#x81f4;AMES&#x7684;EV&#x4f18;&#x52bf;&#x8840;&#x6e05;&#x578b;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Etiology</Keyword><Keyword MajorTopicYN="N">Meningitis</Keyword><Keyword MajorTopicYN="N">Sentinel surveillance</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30744292</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0253-9624.2019.02.010</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>